𝔖 Bobbio Scriptorium
✦   LIBER   ✦

APO2L/TRAIL expression in human brain tumors

✍ Scribed by M. Nakamura; J. Rieger; M. Weller; J. Kim; P. Kleihues; H. Ohgaki


Publisher
Springer-Verlag
Year
2000
Tongue
English
Weight
334 KB
Volume
99
Category
Article
ISSN
0001-6322

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rac2 expression and mutation in human br
✍ S.-L. Hwang; A.-S. Lieu; J.-H. Chang; T.-S. Cheng; C.-Y. Cheng; K.-S. Lee; C.-L. πŸ“‚ Article πŸ“… 2005 πŸ› Springer Vienna 🌐 English βš– 86 KB
TRAIL/Apo-2-ligand-induced apoptosis in
✍ Irmela Jeremias; Ingrid Herr; Thomas Boehler; Klaus-Michael Debatin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 2 views

Members of the tumor necrosis factor (TNF) family such as CD95 (APO-1/Fas) ligand (L) trigger apoptosis in lymphoid cells. Recently, a new member of apoptosis-inducing ligands, TRAIL (TNF-related-apoptosis-inducing-ligand)/Apo-2 ligand, was identified that might act in a similar way. We compared TRA

MMP-7 (matrilysin) expression in human b
✍ Claire Rome; Josette Arsaut; Caroline Taris; Franck Couillaud; Hugues Loiseau πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 318 KB

## Abstract Matrix metalloproteinases (MMP) which degrades protein components of the extra‐cellular matrix and basement membrane seems to be largely involved in cancer invasiveness. MMP proteolitic activity essentially comes from stromal cells but matrilysin (MMP‐7) is produced by the tumor itself.